Together these data support the possibility of HMGB1 as a mediator of fibrogenesis in the liver, and the potential for HMGB1 to be investigated as a predictive biomarker to identify individuals who may be at risk for liver fibrosis progression. This evidence concerns the gene HMGB1 and Hepatic fibrosis.